Semaglutide study to see how brown fat responds in weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how brown fat (a type of body fat) changes after starting semaglutide for weight loss. You may help researchers understand how this medication affects the body’s energy use, which could improve weight-loss treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to start semaglutide for weight loss, and the study won’t provide or pay for it
- You’re over 18 years old and willing to participate
- You are male, or you are a post-menopausal female
- You have never had neck surgery and/or neck radiation (for example, treatment for cancer)
- You can’t be taking beta blockers or any other medicines that lower blood sugar
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study investigates how brown adipose tissue (a special type of fat that burns calories) affects how well semaglutide (Wegovy) works for weight loss. You'll undergo imaging and blood tests while starting semaglutide to help researchers understand individual differences in treatment response.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.